{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:31:33Z","timestamp":1789903893379,"version":"4.0.1"},"publisher-location":"Chichester, UK","reference-count":179,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006612.pub3","type":"reference-entry","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T08:23:11Z","timestamp":1359447791000},"source":"Crossref","is-referenced-by-count":28,"title":["Homocysteine-lowering interventions for preventing cardiovascular events"],"prefix":"10.1002","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Lathyris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina-Elvira","family":"Karakitsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Simancas-Racines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006612.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/STROKEAHA.108.526798","article-title":"High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial","volume":"40","author":"Hodis","year":"2009","journal-title":"Stroke"},{"issue":"Suppl II","key":"10.1002\/14651858.CD006612.pub3-BIB2|cit2","first-page":"741","article-title":"Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial","volume":"106","author":"Baker","year":"2002","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2003.02.001","article-title":"Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial","volume":"93","author":"Liem","year":"2004","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0735-1097(03)00485-6","article-title":"Secondary prevention with folic acid: effects on clinical outcomes","volume":"41","author":"Liem","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/hrt.2004.035030","article-title":"Secondary prevention with folic acid: results of the Goes extension study","volume":"91","author":"Liem","year":"2005","journal-title":"Heart"},{"key":"10.1002\/14651858.CD006612.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/STROKEAHA.108.529503","article-title":"Homocysteine lowering therapy and stroke risk, severity and disability: Results from the HOPE-2 trial","volume":"40","author":"Saposnik","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub3-BIB8|cit8","doi-asserted-by":"crossref","unstructured":"Saposnik G Ray JG Sheridan P McQueen M Lonn E Heart Outcomes Prevention Evaluation Investigators Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial Stroke 2009 1365 72","DOI":"10.1161\/STROKEAHA.108.529503"},{"key":"10.1002\/14651858.CD006612.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.2010.840","article-title":"Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial","volume":"303","author":"Armitage","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB11|cit11","unstructured":"Clinical Trial Service Unit & Epidemiological Studies Unit SEARCH Study Protocol http:\/\/www.searchinfo.org\/SEARCH_protocol.pdf 1 36"},{"issue":"9760","key":"10.1002\/14651858.CD006612.pub3-BIB12|cit12","first-page":"126","article-title":"Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised","volume":"377","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinternmed.2011.1450","article-title":"B vitamin and\/or \u03c9-3 fatty acid supplementation and cancer: Ancillary findings from the supplementation with folate, vitamins B6 and B12, and\/or omega-3 fatty acids (SU.FOL.OM3) randomized trial","volume":"172","author":"Andreeva","year":"2012","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB14|cit14","first-page":"[Epub ahead of","article-title":"Cardiovascular effects of B-vitamins and\/or N-3 fatty acids: The Su.Fol.Om3 trial","volume":"Feb 22","author":"Blacher","year":"2012","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB16|cit15","first-page":"207","article-title":"The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and\/or omega 3 fatty acid supplements in the prevention of recurrent ischemic events","volume":"21","author":"Galan","year":"2009","journal-title":"Sang Thrombose Vaisseaux"},{"key":"10.1002\/14651858.CD006612.pub3-BIB15|cit16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1745-6215-9-35","article-title":"The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and\/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics","volume":"9","author":"Galan","year":"2008","journal-title":"Trials"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub3-BIB19|cit17","first-page":"428","article-title":"Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and\/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries","volume":"7","author":"Galan","year":"2003","journal-title":"The Journal of Nutrition, Health & Aging"},{"key":"10.1002\/14651858.CD006612.pub3-BIB17|cit18","first-page":"36","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial","volume":"342","author":"Galan","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub3-BIB18|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.c6273","article-title":"Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial","volume":"341","author":"Galan","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub3-BIB20|cit20","doi-asserted-by":"crossref","unstructured":"Vesin C Galan P Gautier B Czernichow S Hercberg S Blacher J Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter? European Journal of Cardiovascular Prevention and Rehabilitation 2010 541 8","DOI":"10.1097\/HJR.0b013e3283383f47"},{"key":"10.1002\/14651858.CD006612.pub3-BIB21|cit21","series-title":"Stroke","first-page":"e335","article-title":"Association of a transcobalamin 2 (TCN2) variant located in the 3UTR with post-stroke homocysteine level in subjects from the vitamin intervention for stroke prevention trial","author":"Elias","year":"2010"},{"key":"10.1002\/14651858.CD006612.pub3-BIB22|cit22","series-title":"Stroke","first-page":"e187","article-title":"Sex differences in genetic associations with homocysteine in the vitamin intervention for stroke prevention (VISP) trial","author":"Elkhatib","year":"2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB23|cit23","series-title":"Stroke","first-page":"e334","article-title":"A variant in the adenosine 2B receptor gene is associated with homocysteine levels and stroke severity in african american subjects from the vitamin intervention for stroke prevention (VISP) trial","author":"Sale","year":"2010"},{"key":"10.1002\/14651858.CD006612.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","article-title":"Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial","volume":"36","author":"Dusitanond","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.STR.0000150494.91762.70","article-title":"Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial","volume":"36","author":"Dusitanond","year":"2005","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub3-BIB28|cit28","series-title":"Internal Medicine Journal","first-page":"A110","article-title":"The VITATOPS (VITAmins TO Prevent Stroke) trial: rationale, design and progress of an international, large simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient attack or stroke [Abstract]","year":"2007"},{"key":"10.1002\/14651858.CD006612.pub3-BIB29|cit29","series-title":"Cerebrovascular Diseases","first-page":"11","article-title":"The vitamins to prevent stroke (VITATOPS) trial: results of a double-blind, placebo-controlled, randomised trial of B-vitamin therapy in 8,164 patients with recent transient ischaemic attack or stroke","author":"Hankey","year":"2010"},{"key":"10.1002\/14651858.CD006612.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2261-8-24","article-title":"The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis","volume":"8","author":"Potter","year":"2008","journal-title":"BMC Cardiovascular Disorders"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000199463","article-title":"Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial","volume":"27","author":"Potter","year":"2009","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/STROKEAHA.110.608356","article-title":"The role of vitamin B in stroke prevention: a journey from observational studies to clinical trials and critique of the VITAmins TO Prevent Stroke (VITATOPS)","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub3-BIB33|cit33","first-page":"855-65","article-title":"B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial:a randomised, double-blind, parallel, placebo-controlled trial","volume":"9","year":"2010","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1747-4949.2007.00111.x","article-title":"VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)","volume":"2","author":"Hankey","year":"2007","journal-title":"International Journal of Stroke"},{"issue":"17","key":"10.1002\/14651858.CD006612.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","article-title":"Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial","volume":"299","author":"Albert","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB36|cit36","first-page":"S1137","article-title":"Effect of folic acid and B vitamins on the occurrence of venous thromboembolism: a randomized trial in women at high cardiovascular risk","volume":"118","author":"Glynn","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1002\/14651858.CD006612.pub3-BIB37|cit37","first-page":"52","article-title":"A randomized trial of folic acid and B-vitamins in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)","volume":"16","author":"Redbeg","year":"2006","journal-title":"ACC Cardiosource Review Journal"},{"key":"10.1002\/14651858.CD006612.pub3-BIB39|cit38","doi-asserted-by":"crossref","unstructured":"Song Y Cook NR Albert CM Van Denburgh M Manson JE Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial Diabetes 2009 1921 8","DOI":"10.2337\/db09-0087"},{"key":"10.1002\/14651858.CD006612.pub3-BIB38|cit39","series-title":"Circulation","first-page":"E273","article-title":"Effect of homocysteine-lowering treatment with folic acid and B vitamins on risk of type 2 Diabetes Mellitus in women: a randomized controlled trial","author":"Song","year":"2009"},{"key":"10.1002\/14651858.CD006612.pub3-BIB40|cit40","doi-asserted-by":"crossref","unstructured":"Zhang SM Cook NR Albert CM Gaziano JM Buring JE Manson JE Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial JAMA 2008 2012 21","DOI":"10.1001\/jama.2008.555"},{"key":"10.1002\/14651858.CD006612.pub3-BIB41|cit41","doi-asserted-by":"crossref","unstructured":"Bleie \u00d8 Strand E Ueland PM Vollset SE Refsum H Igland J Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12 Coronary Artery Disease 2011 270 8","DOI":"10.1097\/MCA.0b013e328344fff4"},{"key":"10.1002\/14651858.CD006612.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.amjcard.2010.01.019","article-title":"Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy","volume":"105","author":"Loland","year":"2010","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","article-title":"Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"296","author":"Bazzano","year":"2006","journal-title":"JAMA"},{"issue":"18","key":"10.1002\/14651858.CD006612.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","article-title":"Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials Involving 37 485 individuals","volume":"170","author":"Clarke","year":"2010","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/STROKEAHA.110.578906","article-title":"Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study","volume":"41","author":"Cui","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ejcn.2010.15","article-title":"Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India","volume":"64","author":"Deshmukh","year":"2010","journal-title":"European Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3945\/ajcn.110.006429","article-title":"Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults","volume":"93","author":"Durga","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB49|cit49","first-page":"184","article-title":"Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: Homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events","volume":"30","author":"Ebbing","year":"2009","journal-title":"Journal of Internal Medicine"},{"issue":"19","key":"10.1002\/14651858.CD006612.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.2009.1622","article-title":"Cancer incidence and mortality after treatment with folic acid and vitamin B12","volume":"302","author":"Ebbing","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB51|cit51","unstructured":"Nevado J Folate Intervention in Non-ST elevation myocardial infarction and unstable angina: a randomised placebo-controlled trial http:\/\/controlled-trials.com\/ISRCTN30249553\/homocysteine (accessed Oct 12th 2007)"},{"key":"10.1002\/14651858.CD006612.pub3-BIB52|cit52","doi-asserted-by":"crossref","unstructured":"Green TJ Skeaff CM McMahon JA Venn BJ Williams SM Devlin AM Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations British Journal of Nutrition 2010 1629 34","DOI":"10.1017\/S0007114509993552"},{"issue":"9791","key":"10.1002\/14651858.CD006612.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(11)60872-6","article-title":"Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials","volume":"378","author":"Holmes","year":"2011","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub3-BIB54|cit54","doi-asserted-by":"crossref","unstructured":"Imasa MS Gomez NT Nevado JB Folic acid-based intervention in non-ST elevation acute coronary syndromes Asian Cardiovascular & Thoracic Annals 2009 13 21","DOI":"10.1177\/0218492309102494"},{"key":"10.1002\/14651858.CD006612.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"e3533","DOI":"10.1136\/bmj.e3533","article-title":"The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis","volume":"344","author":"Jardine","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006612.pub3-BIB58|cit57","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","article-title":"Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD006612.pub3-BIB57|cit58","series-title":"Stroke","first-page":"e291","article-title":"Efficacy of homocysteine lowering therapy with folic acid in stroke prevention: A meta-analysis of randomized controlled trials","author":"Lee","year":"2010"},{"key":"10.1002\/14651858.CD006612.pub3-BIB59|cit59","first-page":"481","article-title":"Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?","volume":"14","author":"Lonn","year":"2007","journal-title":"Current Opinion in Hematology ."},{"issue":"6","key":"10.1002\/14651858.CD006612.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amjcard.2009.05.011","article-title":"Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease","volume":"104","author":"Mager","year":"2009","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.18388\/abp.2010_2432","article-title":"Homocysteine and vitamin therapy in stroke prevention and treatment: a review","volume":"57","author":"Manolescu","year":"2010","journal-title":"Acta Biochimica Polonica"},{"key":"10.1002\/14651858.CD006612.pub3-BIB62|cit62","series-title":"Circulation","first-page":"e140","article-title":"Effect of homocysteine interventions on risk of cardiocerebrovascular events: A meta-analysis of randomized controlled trials","author":"Mei","year":"2010"},{"issue":"2","key":"10.1002\/14651858.CD006612.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1742-1241.2009.02207.x","article-title":"Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials","volume":"64","author":"Mei","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB64|cit64","first-page":"235","article-title":"[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]","volume":"50","author":"Mendez-Gonzalez","year":"2010","journal-title":"Revista de Neurolog\u00eda"},{"key":"10.1002\/14651858.CD006612.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjcard.2010.03.064","article-title":"Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels","volume":"106","author":"Miller","year":"2010","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub3-BIB67|cit66","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1179\/016164110X12644252260475","article-title":"Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke","volume":"32","author":"Moghaddasi","year":"2010","journal-title":"Neurological Research"},{"key":"10.1002\/14651858.CD006612.pub3-BIB66|cit67","series-title":"Journal of Neurology","first-page":"S171","article-title":"Homocysteine, vitamin B12 and folic acid levels in cerebrovascular accident: a case-control study","author":"Moghaddasi","year":"2009"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.acvd.2009.07.002","article-title":"The controversial role of B-vitamins in cardiovascular risk: An update","volume":"102","author":"Ntaios","year":"2009","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2009.01.023","article-title":"The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial","volume":"143","author":"Ntaios","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1053\/euhj.2002.3161","article-title":"Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease","volume":"23","author":"Neal","year":"2002","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD006612.pub3-BIB71|cit71","first-page":"Epub ahead of p","article-title":"Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women","volume":"Sep 22","author":"Rautiainen","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub3-BIB72|cit72","first-page":"13","article-title":"The effects of high-dose folic acid on blood pressure of hypertensive adults with hyperhomocysteinemia: A randomized double- blind placebo controlled clinical trial (Tehran homocysteine survey)","volume":"9","author":"Sharifi","year":"2010","journal-title":"Iranian Journal of Diabetes and Lipid Disorders"},{"key":"10.1002\/14651858.CD006612.pub3-BIB73|cit73","doi-asserted-by":"crossref","unstructured":"Shidfar F Homayounfar R Fereshtehnejad SM Kalani A Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial Archives of Medical Research 2009 380 6","DOI":"10.1016\/j.arcmed.2009.06.004"},{"key":"10.1002\/14651858.CD006612.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jama.288.8.973","article-title":"Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial","volume":"288","author":"Schnyder","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB75|cit75","doi-asserted-by":"crossref","unstructured":"Tighe P Ward M McNulty H Finnegan O Dunne A Strain J A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy American Journal of Clinical Nutrition 2011 11 8","DOI":"10.3945\/ajcn.2010.29427"},{"key":"10.1002\/14651858.CD006612.pub3-BIB76|cit76","first-page":"50","article-title":"Efficacy of folic acid in prevention of cerebrovascular disease","volume":"1","author":"Vesin","year":"2007","journal-title":"Medecine des Maladies Metaboliques"},{"key":"10.1002\/14651858.CD006612.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0140-6736(07)60854-X","article-title":"Efficacy of folic acid supplementation in stroke prevention: a meta-analysis","volume":"369","author":"Wang","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","article-title":"Homocysteine and cardiovascular disease: a review of the evidence","volume":"4","author":"Wierzbicki","year":"2007","journal-title":"Diabetes & Vascular Disease Research"},{"key":"10.1002\/14651858.CD006612.pub3-BIB79|cit79","first-page":"55","article-title":"Effect of B vitamins supplementation on cardiovascular and cerebrovascular disease by lowering plasma homocysteine concentration: A meta-analysis. [Chinese]","volume":"1","author":"Zhang","year":"2009","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006612.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"e25142","DOI":"10.1371\/journal.pone.0025142","article-title":"Effect of folic acid supplementation on cardiovascular outcomes: A systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2011","journal-title":"Plos One"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10545-010-9177-4","article-title":"Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects","volume":"34","author":"Blom","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD006612.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub3-BIB84|cit84","first-page":"815-23, 823.e1-","article-title":"Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors","volume":"154","author":"Bowman","year":"2007","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD006612.pub3-BIB85|cit85","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB86|cit86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International journal of epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD006612.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Brozek","year":"2011","journal-title":"Allergy"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0100-879X2009007500021","article-title":"Genetics of homocysteine metabolism and associated disorders","volume":"43","author":"Brustolin","year":"2010","journal-title":"Brazilian Journal of Medical & Biological Research"},{"issue":"9038","key":"10.1002\/14651858.CD006612.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"No authors","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub3-BIB91|cit91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10545-006-0106-5","article-title":"Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview","volume":"29","author":"Castro","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD006612.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MCO.0b013e328011aa71","article-title":"Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia","volume":"10","author":"Clarke","year":"2007","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD006612.pub3-BIB93|cit93","doi-asserted-by":"crossref","unstructured":"Borenstein M Hedges L Higgins J Rothstein H Comprehensive Meta-analysis 2005","DOI":"10.1002\/0471667196.ess3051.pub2"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/nu3030370","article-title":"Folic acid food fortification-its history, effect, concerns, and future directions","volume":"3","author":"Crider","year":"2011","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD006612.pub3-BIB95|cit95","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043798-199808000-00004","article-title":"Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies","volume":"5","author":"Danesh","year":"1998","journal-title":"Journal of Cardiovascular Risk"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbapap.2010.12.006","article-title":"Vitamin B(6) salvage enzymes: mechanism, structure and regulation","volume":"1814","author":"Salvo","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD006612.pub3-BIB98|cit98","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2741\/e428","article-title":"Biomedical aspects of pyridoxal 5'-phosphate availability","volume":"4","author":"Salvo","year":"2012","journal-title":"Frontiers in Bioscience"},{"key":"10.1002\/14651858.CD006612.pub3-BIB99|cit99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/01.CIR.93.9.1755","article-title":"Cardiovascular disease epidemiology: a journey from the past into the future","volume":"93","author":"Epstein","year":"1996","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD006612.pub3-BIB101|cit101","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-94-007-2199-9_18","article-title":"Physiological and molecular aspects of cobalamin transport","volume":"56","author":"Fedosov","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.08.008","article-title":"Structural modifications of HDL and functional consequences","volume":"184","author":"Ferretti","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006612.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ije\/31.1.59","article-title":"Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies","volume":"31","author":"Ford","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB104|cit104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2005-872394","article-title":"Homocysteine: overview of biochemistry, molecular biology, and role in disease processes","volume":"5","author":"Fowler","year":"2005","journal-title":"Seminars in Vascular Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB105|cit105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-94-007-2199-9_14","article-title":"Vitamin B6 and cardiovascular disease","volume":"56","author":"Friso","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB106|cit106","article-title":"Cardiovascular Disease","volume-title":"Disease Control Priorities in Developing Countries","author":"Gaziano","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub3-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1515\/CCLM.2007.347","article-title":"Association between homocysteine, vitamin B(6) concentrations and inflammation","volume":"45","author":"Gori","year":"2007","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB108|cit108","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEpro [Computer program] 2008"},{"key":"10.1002\/14651858.CD006612.pub3-BIB109|cit109","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","article-title":"Homocysteine: role and implications in atherosclerosis","volume":"8","author":"Guthikonda","year":"2006","journal-title":"Current Atherosclerosis Reports"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB112|cit112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD006612.pub3-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB118|cit118","first-page":"Epub ahead of p","article-title":"GRADE guidelines 11-making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"Apr 27","author":"Guyatt","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB119|cit119","doi-asserted-by":"crossref","unstructured":"Guyatt GH Oxman AD Santesso N Helfand M Vist G Kunz R GRADE guidelines 12. Preparing Summary of Findings tables-binary outcomes Journal of Clinical Epidemiology 2012 Epub ahead of print","DOI":"10.1016\/j.jclinepi.2012.01.012"},{"key":"10.1002\/14651858.CD006612.pub3-BIB120|cit120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence","volume":"290","author":"Hackam","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB121|cit121","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-94-007-2199-9_16","article-title":"Cobalamin deficiency","volume":"56","author":"Herrmann","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB122|cit122","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub3-BIB123|cit123","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB124|cit124","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/82.4.806","article-title":"Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials","volume":"82","year":"2005","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD006612.pub3-BIB125|cit125","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB126|cit126","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD006612.pub3-BIB127|cit127","volume-title":"Code of Federal Regulations & International Conference on Harmonisation Guidelines","year":"1997"},{"issue":"3-4","key":"10.1002\/14651858.CD006612.pub3-BIB128|cit128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: The art of getting it wrong","volume":"10","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD006612.pub3-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1515\/CCLM.2005.188","article-title":"Molecular targeting by homocysteine: a mechanism for vascular pathogenesis","volume":"43","author":"Jacobsen","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB130|cit130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.ki.5000235","article-title":"Homocysteine targeting of plasma proteins in hemodialysis patients","volume":"69","author":"Jacobsen","year":"2006","journal-title":"Kidney International"},{"issue":"2S Suppl","key":"10.1002\/14651858.CD006612.pub3-BIB131|cit131","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1093\/jn\/130.2.377S","article-title":"Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans","volume":"130","author":"Jakubowski","year":"2000","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub3-BIB132|cit132","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-003-3204-7","article-title":"Molecular basis of homocysteine toxicity in humans","volume":"61","author":"Jakubowski","year":"2004","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1002\/14651858.CD006612.pub3-BIB133|cit133","first-page":"155","article-title":"The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease","volume":"59 (Suppl 9)","author":"Jakubowski","year":"2008","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB134|cit134","doi-asserted-by":"crossref","DOI":"10.1596\/978-0-8213-6260-0","volume-title":"Priorities in Health","author":"Jamison","year":"2006"},{"issue":"10","key":"10.1002\/14651858.CD006612.pub3-BIB135|cit135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006612.pub3-BIB136|cit136","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCULATIONAHA.108.190186","article-title":"The impact of prevention on reducing the burden of cardiovascular disease","volume":"118","author":"Kahn","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB137|cit137","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2010.10.005","article-title":"Homocysteine as a new risk factor for cardiovascular events in heart failure","volume":"146","author":"Kardesoglu","year":"2011","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB138|cit138","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-94-007-2199-9_17","article-title":"Biochemistry of B12-cofactors in human metabolism","volume":"56","author":"Kr\u00e4utler","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB139|cit139","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for Studies In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB140|cit140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cll.2006.06.008","article-title":"Homocysteine","volume":"26","author":"Maron","year":"2006","journal-title":"Clinics in Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB141|cit141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.med.60.041807.123308","article-title":"The treatment of hyperhomocysteinemia","volume":"60","author":"Maron","year":"2009","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB142|cit142","first-page":"590","article-title":"Steps to control the burden of cardiovascular disease in the Indian Subcontinent","volume":"125","author":"Math","year":"2007","journal-title":"The Indian Journal of Medical Research"},{"key":"10.1002\/14651858.CD006612.pub3-BIB143|cit143","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1515\/CCLM.2005.172","article-title":"Hyperhomocysteinemia and arteriosclerosis: historical perspectives","volume":"43","author":"McCully","year":"2005","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB144|cit144","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-2199-9_7","article-title":"Genetic aspects of folate metabolism","volume":"56","author":"Molloy","year":"2012","journal-title":"Sub-cellular Biochemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB145|cit145","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.20.7.1704","article-title":"Homocysteine and its disulfide derivatives: a suggested consensus terminology","volume":"20","author":"Mudd","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"11","key":"10.1002\/14651858.CD006612.pub3-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.bbapap.2011.06.018","article-title":"Pyridoxal phosphate: biosynthesis and catabolism","volume":"1814","author":"Mukherjee","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD006612.pub3-BIB147|cit147","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1373\/clinchem.2008.115899","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease","volume":"55","author":"Myers","year":"2009","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD006612.pub3-BIB148|cit148","article-title":"Diabetes: the pandemic and potential solutions","volume-title":"Disease Control Priorities in Developing Countries","author":"Narayan","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub3-BIB149|cit149","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.febslet.2009.03.038","article-title":"Homocysteine and lipids: S-adenosyl methionine as a key intermediate","volume":"583","author":"Obeid","year":"2009","journal-title":"FEBS Letters"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB150|cit150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/nu3040475","article-title":"Human folate bioavailability","volume":"3","author":"Ohrvik","year":"2011","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD006612.pub3-BIB151|cit151","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","article-title":"Mechanisms of homocysteine toxicity in humans","volume":"32","author":"Per\u0142a-Kaj\u00e1n","year":"2007","journal-title":"Amino Acids"},{"key":"10.1002\/14651858.CD006612.pub3-BIB152|cit152","first-page":"275","article-title":"Biochemistry of homocysteine in health and diseases","volume":"43","author":"Ramakrishnan","year":"2006","journal-title":"Indian Journal of Biochemistry & Biophysics"},{"key":"10.1002\/14651858.CD006612.pub3-BIB153|cit153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.med.49.1.31","article-title":"Homocysteine and cardiovascular disease","volume":"49","author":"Refsum","year":"1998","journal-title":"Annual Review of Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB154|cit154","unstructured":"The Nordic Cochrane Centre: The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB155|cit155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.ATV.0000150651.85907.69","article-title":"Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia","volume":"25","author":"Riksen","year":"2005","journal-title":"Arteriosclerosis, Thrombosis & Vascular Biology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB156|cit156","article-title":"The growing burden of risk from high blood pressure, cholesterol, and bodyweight","volume-title":"Disease Control Priorities in Developing Countries","author":"Rodgers","year":"2006"},{"key":"10.1002\/14651858.CD006612.pub3-BIB157|cit157","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD006612.pub3-BIB158|cit158","doi-asserted-by":"crossref","first-page":"1726S","DOI":"10.1093\/jn\/136.6.1726S","article-title":"The many facets of hyperhomocysteinemia: studies from the Framingham cohorts","volume":"136","author":"Selhub","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD006612.pub3-BIB159|cit159","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/15648265080292S116","article-title":"Public health significance of elevated homocysteine","volume":"29 (Suppl 2)","author":"Shelhub","year":"2008","journal-title":"Food and Nutrition Bulletin"},{"key":"10.1002\/14651858.CD006612.pub3-BIB160|cit160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2007.09.009","article-title":"Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels","volume":"198","author":"Sofi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD006612.pub3-BIB161|cit161","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ahj.2004.02.004","article-title":"Homocysteine and cardiovascular disease: biological mechanism, observational epidemiology, and the need for randomised trials","volume":"148","author":"Splaver","year":"2004","journal-title":"American Heart Journal"},{"issue":"8934","key":"10.1002\/14651858.CD006612.pub3-BIB162|cit162","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"No authors","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006612.pub3-BIB163|cit163","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB164|cit164","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB165|cit165","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB166|cit166","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) http:\/\/ctu.dk\/tsa\/files\/tsa_manual.pdf 2011 (accessed 30 April 2012). 2011"},{"key":"10.1002\/14651858.CD006612.pub3-BIB167|cit167","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1542-4758.2007.00171.x","article-title":"Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events","volume":"11","author":"Vianna","year":"2007","journal-title":"Hemodialysis International"},{"key":"10.1002\/14651858.CD006612.pub3-BIB168|cit168","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006612.pub3-BIB169|cit169","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ddmec.2005.05.029","article-title":"Mechanisms in homocysteine-induced vascular disease","volume":"2","author":"Wang","year":"2005","journal-title":"Drug Discovery Today: Disease Mechanisms"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB170|cit170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB171|cit171","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD006612.pub3-BIB172|cit172","volume-title":"The world health report: reducing risks, promoting healthy life. Available at http:\/\/www.who.int\/whr\/2002\/en\/whr02_en.pdf [accessed 01 01 2007]","year":"2002"},{"key":"10.1002\/14651858.CD006612.pub3-BIB173|cit173","article-title":"Prevention of chronic disease by means of diet and lifestyle changes","volume-title":"Disease Control Priorities in Developing Countries","author":"Willett","year":"2006"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB174|cit174","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.71","article-title":"Homocysteine metabolism and its relation to health and disease","volume":"36","author":"Williams","year":"2010","journal-title":"Bifactors"},{"key":"10.1002\/14651858.CD006612.pub3-BIB175|cit175","article-title":"Technical aspects of food fortification","volume-title":"Food and Nutrition Bulletin","volume":"19","author":"Wirakartakusumah","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD006612.pub3-BIB176|cit176","doi-asserted-by":"crossref","first-page":"322S","DOI":"10.3945\/ajcn.111.013300","article-title":"Folate and vitamin B-12 biomarkers in NHANES: history of their measurement and use","volume":"94","author":"Yetley","year":"2011","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD006612.pub3-BIB177|cit177","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006612.pub3-BIB178|cit178","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/biof.17","article-title":"Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms","volume":"35","author":"Zhou","year":"2009","journal-title":"Biofactors"},{"issue":"4","key":"10.1002\/14651858.CD006612.pub3-BIB179|cit179","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006612.pub2","article-title":"Homocysteine lowering interventions for preventing cardiovascular events","author":"Marti-Carvajal","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006612.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:52:59Z","timestamp":1714881179000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006612.pub3"}},"subtitle":[],"editor":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":179,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006612.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985662.793476548","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,1,31]]}}}